Corticosteroids in TBI: Is the story closed?

Journal of Head Trauma Rehabilitation

Volumn 21, Issue 3, 2006, Pages 285-288

  Rigg, John L ^a   Zafonte, Ross D ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GLUCOCORTICOID; LAZAROID; METHYLPREDNISOLONE; MINERALOCORTICOID; PLACEBO; TIRILAZAD;

ADRENAL INSUFFICIENCY; ANTIOXIDANT ACTIVITY; BRAIN EDEMA; BRAIN HEMORRHAGE; CELL PROTECTION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DRUG EFFECT; DRUG MECHANISM; EXPERIMENTAL ANIMAL; HEART PROTECTION; HUMAN; HYPOTENSION; INTRACRANIAL PRESSURE; LIPID PEROXIDATION; MORBIDITY; MORTALITY; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PREDICTION; REVIEW; RISK REDUCTION; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW; TRAUMATIC BRAIN INJURY;

ADRENAL CORTEX HORMONES; ANIMALS; BRAIN INJURIES; HUMANS; LIPID PEROXIDATION; NEUROPROTECTIVE AGENTS;

EID: 33748142939     PISSN: 08859701     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001199-200605000-00010     Document Type: Review

References (15)

1. Cernak I. Animal models of head trauma. NeuroRx. 2005;2(3):410-422.
2. DeKosky ST, Kochanek PM, Clark RS, Ciallella JR, Dixon CE. Secondary injury after head trauma: sub-acute and long-term mechanisms. Semin Clin Neuropsychiatry. 1998;3:176-185.
3. Segatore M. Corticosteroids and traumatic brain injury: status at the end of the decade of the brain. J Neurosci Nurs. 1999;31(4):239-250.
4. Park CO. The effects of methylprednisolone on prevention of brain edema after experimental moderate diffuse brain injury in rats - comparison between dosage, injection time, and treatment methods. Yonsei Med J. 1998;39(5):395-403.
5. Emir M, Ozisik K, Cagli K, et al. Beneficial effect of methylprednisolone on cardiac myocytes in a rat model of severe brain injury. Tohoku J Exp Med. 2005;207(2):119-124.
6. Kavanagh RJ, Kam PC. Lazaroids: efficacy and mechanism of action of the 21-aminosteroids in neuroprotection. Br J Anaesth. 2001;86(1):110-119.
7. Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury: results of the Second National Acute Spinal Cord Injury Study. N Engl J Med. 1990;322:1405-1411.
8. Bracken MB, Shepard MJ, Holford TR, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury: results of the Third National Acute Spinal Cord Injury Trial. National Acute Spinal Cord Injury Study. JAMA. 1997;277:1597-1604.
9. Gallich JH, French LA. The use of dexamethasone in the treatment of cerebral edema resulting from brain tumors and brain surgery. Am Pract Dig Treat. 1961;12:169-174.
10. The Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Role of steroids. J Neurotrauma. 2000;17(6/7):531-535.
11. Adelson PD, Bratton SL, Carney NA, et al. Chapter 16. The use of corticosteroids in the treatment of severe pediatric traumatic brain injury. Pediatr Crit Care Med. 2003;4(3, suppl):S60-S64.
12. Roberts I, Yates D, Sandercock P, et al. CRASH trial collaborators: effect of intravenous corticosteroids on death within 14 days in 10,008 adults with clinically significant head injury (MRC CRASH trial): randomized placebo-controlled trial. Lancet. 2004;364:1321-1328.
13. Alderson P, Roberts I. Glucocorticoids for acute traumatic brain injury (Cochrane review). In: The Cochrane Library. Issue 2. Chichester, UK: John Wiley and Sons; 2004.
14. Gomes JA, Stevens RD, Lewin JJ III, Mirski MA, Bhardwaj A. Glucocorticoid therapy in neurologic critical care. Crit Care Med. 2005;33(6):1214-1224.
15. Cohan P, Wang C, McArthur DL, et al. Acute secondary adrenal insufficiency after traumatic brain injury: a prospective study. Crit Care Med. 2005;33(10):2358-2366.